West Pharmaceutical Services (WST) Non Operating Income (2011 - 2026)
West Pharmaceutical Services' (WST) quarterly Non Operating Income came in at -$200000.0 in Q1 2026, little changed year-on-year from -$200000.0 in Q1 2025, and up 99.6% quarter-over-quarter from -$50.6 million in Q4 2025.
West Pharmaceutical Services (WST) Non Operating Income (2011 - 2026) Analysis & Trends
West Pharmaceutical Services has disclosed Non Operating Income across 16 years of filings, most recently posting -$200000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$200000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$57.9 million (down 1186.67% YoY), and the FY2025 annual result was -$51.2 million, down 5020.0% from the prior year.
- Non Operating Income came in at -$200000.0 for Q1 2026 at West Pharmaceutical Services, up from -$50.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $25.5 million in Q4 2023 to a low of -$50.6 million in Q4 2025.
- The 5-year median for Non Operating Income is -$950000.0 (2022), against an average of -$3.4 million.
- Across the five-year window, Non Operating Income jumped 1259.09% in 2023 and tumbled 16766.67% in 2025, its largest moves.
- West Pharmaceutical Services' Non Operating Income stood at -$2.2 million in 2022, then soared by 1259.09% to $25.5 million in 2023, then sank by 101.18% to -$300000.0 in 2024, then sank by 16766.67% to -$50.6 million in 2025, then surged by 99.6% to -$200000.0 in 2026.
- The last three Non Operating Income figures came in at -$200000.0 (Q1 2026), -$50.6 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 85.10 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 86.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -131.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -1.37 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -200,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -4.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.02 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200,000.00 |
| Dec 31, 2025 | -50.60 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -700,000.00 |
| Jun 30, 2024 | -3.30 Mn |
| Dec 31, 2023 | 25.50 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | -12.90 Mn |
| Dec 31, 2022 | -2.20 Mn |
| Sep 30, 2022 | -1.90 Mn |
| Jun 30, 2022 | -1.20 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | -2.10 Mn |
| Sep 30, 2021 | -300,000.00 |
| Jun 30, 2021 | 2.70 Mn |
| Mar 31, 2021 | -3.90 Mn |